Fortive Corporation Peer Comparison

Metric Value Ranking
Market Cap $25.4 Billion 2/13 IIVI
$30.5B		 FTV
$25.4B		 TDY
$23.4B		 TRMB
$17.6B		 COHR
$10.6B		 MKSI
$6.1B		 BMI
$5.8B		 ITRI
$4.9B		 NOVT
$4.8B		 ST
$4.2B		 ESE
$4.2B		 MLAB
$671.1M		 VPG
$298.6M
Gross Margin 60% 3/13 TRMB
71%		 MLAB
63%		 FTV
60%		 MKSI
47%		 NOVT
45%		 TDY
43%		 BMI
40%		 ESE
40%		 VPG
38%		 IIVI
35%		 COHR
35%		 ITRI
35%		 ST
27%
Profit Margin 13% 2/13 BMI
15%		 FTV
13%		 TDY
13%		 MKSI
10%		 ESE
10%		 TRMB
9%		 ITRI
9%		 IIVI
7%		 COHR
7%		 NOVT
7%		 ST
1%		 VPG
1%		 MLAB
-3%
EBITDA margin 19% 5/13 IIVI
23%		 COHR
23%		 TRMB
23%		 TDY
21%		 FTV
19%		 BMI
19%		 ESE
19%		 ITRI
15%		 MKSI
14%		 NOVT
11%		 MLAB
10%		 ST
8%		 VPG
0%
Quarterly Revenue $1.6 Billion 1/13 FTV
$1.6B		 TDY
$1.5B		 IIVI
$1.4B		 COHR
$1.4B		 TRMB
$983.4M		 MKSI
$935.0M		 ST
$907.7M		 ITRI
$612.9M		 ESE
$247.0M		 NOVT
$238.1M		 BMI
$205.2M		 VPG
$72.7M		 MLAB
$62.8M
Quarterly Earnings $208.8 Million 1/13 FTV
$208.8M 		TDY
$198.5M 		IIVI
$103.4M 		COHR
$103.4M 		TRMB
$90.2M 		MKSI
$90.0M 		ITRI
$58.1M 		BMI
$30.7M 		ESE
$23.5M 		NOVT
$16.5M 		ST
$5.8M 		VPG
$768,000 		MLAB
-$1.7M
Quarterly Free Cash Flow $0 Million 8/13 IIVI
$81.7B 		COHR
$81.7B 		TDY
$303.4M 		TRMB
$109.0M 		ITRI
$70.2M 		ESE
$29.0M 		MLAB
$17.6M 		FTV
-$0 		MKSI
-$0 		ST
-$0 		NOVT
-$0 		BMI
-$0 		VPG
-$0
Trailing 4 Quarters Revenue $6.2 Billion 2/13 ST
$985.8B		 FTV
$6.2B		 TDY
$5.7B		 IIVI
$4.1B		 COHR
$4.1B		 TRMB
$3.7B		 MKSI
$3.6B		 ITRI
$2.4B		 ESE
$1.1B		 NOVT
$949.2M		 BMI
$826.6M		 VPG
$306.5M		 MLAB
$237.7M
Trailing 4 Quarters Earnings $832.9 Million 2/13 FTV
$1.6B 		TDY
$1.5B 		IIVI
$1.4B 		COHR
$1.4B 		TRMB
$983.4M 		MKSI
$935.0M 		ST
$907.7M 		ITRI
$612.9M 		ESE
$247.0M 		NOVT
$238.1M 		BMI
$205.2M 		VPG
$72.7M 		MLAB
$62.8M
Quarterly Earnings Growth -21% 10/13 IIVI
483% 		COHR
483% 		MKSI
232% 		ST
103% 		ESE
55% 		TRMB
43% 		NOVT
32% 		ITRI
31% 		BMI
24% 		FTV
-21% 		TDY
-39% 		VPG
-82% 		MLAB
-179%
Annual Earnings Growth -9% 8/13 TRMB
423% 		MKSI
288% 		IIVI
206% 		COHR
206% 		ITRI
45% 		BMI
22% 		ESE
-1% 		FTV
-9% 		TDY
-11% 		NOVT
-16% 		VPG
-57% 		MLAB
-15748% 		ST
-179737%
Quarterly Revenue Growth 71% 1/13 FTV
71% 		IIVI
27% 		COHR
27% 		MLAB
18% 		NOVT
13% 		ESE
13% 		BMI
12% 		ITRI
6% 		TRMB
5% 		MKSI
5% 		TDY
5% 		ST
-9% 		VPG
-19%
Annual Revenue Growth 15% 2/13 ST
24567% 		FTV
15% 		BMI
12% 		MLAB
12% 		NOVT
8% 		ITRI
8% 		ESE
2% 		TDY
1% 		TRMB
-3% 		MKSI
-3% 		IIVI
-5% 		COHR
-5% 		VPG
-12%
Cash On Hand $813.3 Million 4/13 IIVI
$917.8B 		COHR
$917.8B 		ITRI
$1.1B 		FTV
$813.3M 		TRMB
$738.8M 		MKSI
$714.0M 		TDY
$649.8M 		ST
$593.7M 		BMI
$295.3M 		NOVT
$114.0M 		ESE
$71.3M 		MLAB
$31.0M 		VPG
-$0
Short Term Debt $376.2 Million 3/13 IIVI
$68.3B 		COHR
$68.3B 		FTV
$376.2M 		MLAB
$100.9M 		MKSI
$50.0M 		ESE
$20.0M 		NOVT
$4.7M 		VPG
$4.0M 		ST
$2.4M 		TDY
$300,000 		TRMB
-$0 		ITRI
-$0 		BMI
-$0
Long Term Debt $3.3 Billion 3/13 IIVI
$4.0T		 COHR
$4.0T		 FTV
$3.3B		 TDY
$2.6B		 TRMB
$1.5B		 NOVT
$452.5M		 MKSI
$211.0M		 ITRI
$182.9M		 ESE
$128.4M		 VPG
$51.4M		 MLAB
$27.0M		 ST
$21.0M		 BMI
$0
PE 30.50 7/13 IIVI
125.68		 NOVT
75.31		 BMI
46.29		 COHR
43.85		 ESE
37.82		 MKSI
32.12		 FTV
30.50		 VPG
30.12		 TDY
28.53		 ITRI
20.35		 TRMB
11.70		 ST
-1.00		 MLAB
-1.00
PS 4.08 6/13 IIVI
7.46		 BMI
7.00		 NOVT
5.08		 TRMB
4.78		 TDY
4.12		 FTV
4.08		 ESE
3.95		 MLAB
2.82		 COHR
2.60		 ITRI
1.99		 MKSI
1.70		 VPG
0.97		 ST
0.00
PB 2.49 8/13 BMI
8.33		 NOVT
6.47		 MLAB
4.32		 ITRI
3.45		 ESE
3.37		 TRMB
3.06		 MKSI
2.63		 FTV
2.49		 TDY
2.45		 ST
1.44		 IIVI
0.00		 COHR
0.00		 VPG
0.00
PC 31.24 4/13 ESE
58.46		 NOVT
42.34		 TDY
35.99		 FTV
31.24		 TRMB
23.83		 MLAB
21.68		 BMI
19.58		 MKSI
8.55		 ST
7.03		 ITRI
4.63		 IIVI
0.03		 COHR
0.01		 VPG
-1.00
Liabilities to Equity 0.67 8/13 MKSI
2.70		 MLAB
1.82		 ST
1.47		 ITRI
1.44		 IIVI
1.21		 COHR
1.21		 NOVT
0.86		 FTV
0.67		 TRMB
0.65		 TDY
0.49		 ESE
0.44		 VPG
0.40		 BMI
0.15
ROA 0.05 6/13 TRMB
16% 		BMI
15% 		ITRI
7% 		TDY
6% 		ESE
6% 		FTV
5% 		NOVT
5% 		MKSI
2% 		IIVI
0% 		COHR
0% 		MLAB
-57% 		VPG
-100% 		ST
-348%
ROE 0.08 7/13 TRMB
26% 		ITRI
17% 		BMI
15% 		NOVT
9% 		TDY
9% 		ESE
9% 		FTV
8% 		MKSI
8% 		VPG
3% 		IIVI
0% 		COHR
0% 		MLAB
-161% 		ST
-861%
Current Ratio 2.49 5/13 BMI
6.70		 ESE
3.22		 TDY
3.06		 TRMB
2.53		 FTV
2.49		 IIVI
2.28		 COHR
2.28		 NOVT
2.16		 ITRI
1.71		 ST
1.68		 MLAB
1.55		 MKSI
1.37		 VPG
0.00
Quick Ratio 0.12 10/13 IIVI
125.68		 NOVT
75.31		 BMI
46.29		 COHR
43.85		 ESE
37.82		 MKSI
32.12		 FTV
30.50		 VPG
30.12		 TDY
28.53		 ITRI
20.35		 TRMB
11.70		 ST
-1.00		 MLAB
-1.00
Long Term Debt to Equity 0.33 4/13 IIVI}
0.77		 COHR}
0.77		 NOVT}
0.61		 FTV}
0.33		 TDY}
0.28		 TRMB}
0.26		 MLAB}
0.17		 VPG}
0.16		 ITRI}
0.13		 ESE}
0.10		 MKSI}
0.09		 ST}
0.01		 BMI}
0.00
Debt to Equity 0.36 5/13 MLAB
0.82		 IIVI
0.79		 COHR
0.79		 NOVT
0.61		 FTV
0.36		 TDY
0.28		 TRMB
0.26		 VPG
0.17		 ESE
0.12		 MKSI
0.11		 ITRI
0.11		 ST
0.01		 BMI
0.00
Burn Rate 43.98 1/13 FTV
43.98		 NOVT
40.59		 IIVI
5.19		 COHR
5.19		 MLAB
1.11		 VPG
0.00		 ESE
-5.34		 TDY
-7.03		 BMI
-9.61		 MKSI
-10.34		 ITRI
-20.70		 TRMB
-24.93		 ST
-136.66
Cash to Cap 0.03 9/13 COHR
86.20		 IIVI
30.08		 ITRI
0.22		 ST
0.14		 MKSI
0.12		 BMI
0.05		 MLAB
0.05		 TRMB
0.04		 FTV
0.03		 TDY
0.03		 NOVT
0.02		 ESE
0.02		 VPG
0.00
CCR 8/13 IIVI
790.21		 COHR
790.21		 TDY
1.53		 ESE
1.23		 TRMB
1.21		 ITRI
1.21		 MLAB
-10.52		 FTV
 MKSI
 ST
 NOVT
 BMI
 VPG
EV to EBITDA 92.15 8/13 IIVI}
9711.10		 COHR}
9650.37		 VPG}
1778.50		 NOVT}
193.56		 BMI}
139.91		 MLAB}
125.45		 ESE}
92.26		 FTV}
92.15		 TRMB}
80.35		 TDY}
79.08		 ST}
48.83		 ITRI}
43.78		 MKSI}
41.85
EV to Revenue 4.54 6/13 IIVI
777.19		 COHR
772.33		 BMI
6.64		 NOVT
5.45		 TRMB
4.99		 FTV
4.54		 TDY
4.48		 ESE
4.02		 MLAB
3.23		 ITRI
1.63		 MKSI
1.58		 VPG
1.15		 ST
0.00

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions